Enzon Pharmaceuticals Probability of Future OTC Stock Price Finishing Under 0.16
| ENZNDelisted Stock | USD 0.20 0.01 5.26% |
Enzon |
Enzon Pharmaceuticals Target Price Odds to finish below 0.16
The tendency of Enzon OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.16 or more in 90 days |
| 0.20 | 90 days | 0.16 | about 24.13 |
Based on a normal probability distribution, the odds of Enzon Pharmaceuticals to drop to $ 0.16 or more in 90 days from now is about 24.13 (This Enzon Pharmaceuticals probability density function shows the probability of Enzon OTC Stock to fall within a particular range of prices over 90 days) . Probability of Enzon Pharmaceuticals price to stay between $ 0.16 and its current price of $0.2 at the end of the 90-day period is about 51.56 .
Given the investment horizon of 90 days Enzon Pharmaceuticals has a beta of 0.28 suggesting as returns on the market go up, Enzon Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Enzon Pharmaceuticals will be expected to be much smaller as well. Additionally Enzon Pharmaceuticals has an alpha of 0.1196, implying that it can generate a 0.12 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Enzon Pharmaceuticals Price Density |
| Price |
Predictive Modules for Enzon Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enzon Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Enzon Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Enzon Pharmaceuticals is not an exception. The market had few large corrections towards the Enzon Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Enzon Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Enzon Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.12 | |
β | Beta against Dow Jones | 0.28 | |
σ | Overall volatility | 0.03 | |
Ir | Information ratio | 0 |
Enzon Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Enzon Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Enzon Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Enzon Pharmaceuticals is not yet fully synchronised with the market data | |
| Enzon Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Enzon Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 701 K. Net Loss for the year was (469 K) with profit before overhead, payroll, taxes, and interest of 701 K. | |
| Enzon Pharmaceuticals currently holds about 46.79 M in cash with (501 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Enzon Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Enzon OTC Stock often depends not only on the future outlook of the current and potential Enzon Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enzon Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74.2 M | |
| Forward Annual Dividend Rate | 0.12 | |
| Shares Float | 30.2 M |
Enzon Pharmaceuticals Technical Analysis
Enzon Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Enzon OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Enzon Pharmaceuticals. In general, you should focus on analyzing Enzon OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Enzon Pharmaceuticals Predictive Forecast Models
Enzon Pharmaceuticals' time-series forecasting models is one of many Enzon Pharmaceuticals' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Enzon Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Enzon Pharmaceuticals
Checking the ongoing alerts about Enzon Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Enzon Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Enzon Pharmaceuticals is not yet fully synchronised with the market data | |
| Enzon Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Enzon Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 701 K. Net Loss for the year was (469 K) with profit before overhead, payroll, taxes, and interest of 701 K. | |
| Enzon Pharmaceuticals currently holds about 46.79 M in cash with (501 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Enzon OTC Stock
If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stocks Directory Find actively traded stocks across global markets |